Promotion of Tumor Progression Induced by Continuous Low-Dose Administration of Antineoplastic Agent Gemcitabine or Gemcitabine Combined with Cisplatin.
Life sciences（2022）
Key words
Low-dosage chemotherapy,Antineoplastic agents,Metronomic chemotherapy,Bone marrow derived cell,Angiogenesis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined